Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
作者信息
Cohen P, Peehl D M, Rosenfeld R
出版信息
Br J Cancer. 1998 Aug;78(4):554-6. doi: 10.1038/bjc.1998.535.
Abstract
摘要
相似文献
1
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.胰岛素样生长因子1与前列腺癌和良性前列腺增生的关系
Br J Cancer. 1998 Aug;78(4):554-6. doi: 10.1038/bjc.1998.535.
2
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.胰岛素样生长因子1与前列腺癌和良性前列腺增生的关系。
Br J Cancer. 1997;76(9):1115-8. doi: 10.1038/bjc.1997.520.
3
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.前列腺癌和良性前列腺增生患者体内的胰岛素样生长因子结合蛋白-2
Clin Endocrinol (Oxf). 1997 Mar;46(3):333-42.
4
Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer.良性前列腺增生症和前列腺癌中的胰岛素样生长因子I（IGF-I）及IGF结合蛋白-3
J Clin Endocrinol Metab. 2001 Feb;86(2):694-9. doi: 10.1210/jcem.86.2.7211.
5
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.前列腺癌和良性前列腺增生患者体内的胰岛素样生长因子结合蛋白-2
Clin Endocrinol (Oxf). 1997 Feb;46(2):145-54.
6
7
Letter to the Editor involving in the article "Gene expression of insulin receptor, insulin-like growth factor increases and insulin-like growth factor-binding protein-3 reduces with increase in prostate size in benign prostatic hyperplasia".
Aging Male. 2018 Sep;21(3):223. doi: 10.1080/13685538.2018.1428950. Epub 2018 Feb 1.
8
9
The comparison between vitamin d concentration in upper silesia patients with prostate cancer and with benign prostatic hyperplasia.上西里西亚地区前列腺癌患者与良性前列腺增生患者维生素D浓度的比较。
J Biol Regul Homeost Agents. 2015 Jan-Mar;29(1):207-11.
10
Serum interleukin-11 in patients with benign prostatic hyperplasia and prostate cancer.
Int Urol Nephrol. 2005;37(1):69-71. doi: 10.1007/s11255-004-6086-1.
引用本文的文献
1
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.未诊断为前列腺癌的男性中报告的前列腺癌风险等位基因与前列腺特异性抗原水平的关联。
Prostate. 2009 Mar 1;69(4):419-27. doi: 10.1002/pros.20908.
2
Association of prostate-specific antigen promoter genotype with clinical and histopathologic features of prostate cancer.前列腺特异性抗原启动子基因型与前列腺癌临床及组织病理学特征的关联
Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2451-7. doi: 10.1158/1055-9965.EPI-08-0374.
3
A system for studying epithelial-stromal interactions reveals distinct inductive abilities of stromal cells from benign prostatic hyperplasia and prostate cancer.一种用于研究上皮-基质相互作用的系统揭示了来自良性前列腺增生和前列腺癌的基质细胞具有不同的诱导能力。
Endocrinology. 2005 Jan;146(1):13-8. doi: 10.1210/en.2004-1123. Epub 2004 Oct 7.
本文引用的文献
1
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.胰岛素样生长因子1与前列腺癌和良性前列腺增生的关系。
Br J Cancer. 1997;76(9):1115-8. doi: 10.1038/bjc.1997.520.
2
Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia.前列腺癌和良性前列腺增生患者体内的胰岛素样生长因子结合蛋白-2
Clin Endocrinol (Oxf). 1997 Mar;46(3):333-42.
3
Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen.前列腺癌患者血清胰岛素样生长因子结合蛋白-2（IGFBP-2）水平升高，而胰岛素样生长因子结合蛋白-3（IGFBP-3）水平降低：与血清前列腺特异性抗原的相关性
J Clin Endocrinol Metab. 1993 Jul;77(1):229-33. doi: 10.1210/jcem.77.1.7686915.
4
Comparison of the effectiveness of various procedures for reducing or eliminating insulin-like growth factor-binding protein interference with insulin-like growth factor-I radioimmunoassays on porcine sera.
J Endocrinol. 1994 Feb;140(2):229-37. doi: 10.1677/joe.0.1400229.
5
A child with phenotypic Laron dwarfism and normal somatomedin levels.
N Engl J Med. 1989 Feb 9;320(6):376-9. doi: 10.1056/NEJM198902093200607.
6
A child with phenotypic Laron dwarfism and normal somatomedin levels.
N Engl J Med. 1989 Jun 22;320(25):1698-9. doi: 10.1056/NEJM198906223202516.
7
Serum somatomedin binding proteins: physiologic significance and interference in radioligand assay.血清生长调节素结合蛋白：生理意义及对放射配体分析的干扰
J Lab Clin Med. 1987 Mar;109(3):355-63.
8
Correction and withdrawal of conclusion--a child with phenotypic Laron dwarfism and normal somatomedin levels.
N Engl J Med. 1990 Nov 22;323(21):1485.
9
Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand.
Acta Endocrinol (Copenh). 1991 Jun;124(6):620-9. doi: 10.1530/acta.0.1240620.
Zotero 插件